Analysis of Clinical Characteristics and Study of Diagnostic Markers in Patients with Polycystic Ovary Syndrome

Launched by SHANGHAI 10TH PEOPLE'S HOSPITAL · Sep 21, 2021

Keywords

ClinConnect Summary

This clinical trial is studying women with Polycystic Ovary Syndrome (PCOS) to better understand how different factors in their bodies, like hormones and metabolism, relate to their health. Researchers are collecting health information and blood samples from participants to identify potential new markers that could help tailor more effective treatments for PCOS. Essentially, the goal is to find ways to personalize care for women diagnosed with this condition.

To participate in this study, women must be between the ages of 18 and 45 and meet specific criteria known as the Rotterdam criteria for PCOS. However, women who are pregnant, planning to become pregnant, or have certain medical conditions (like thyroid disorders or liver issues) cannot join. If eligible, participants can expect to provide health information and blood samples while contributing to important research that could lead to better treatment options for PCOS in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Female aged 18- 45;
• • Meet Rotterdam criteria;
• Exclusion Criteria:
• • Women who are pregnant or have a pregnancy plan within six months;
• • Congenital adrenocortical hyperplasia;
• • Hyperprolactinemia;
• • Hyperthyroidism or hypothyroidism;
• • Abnormal liver function (≥ 3 times of the upper limit of normal range);
• • Abnormal renal function (GFR\<60ml/min/1.73m2);
• • Adrenal or ovarian tumors secreting androgens;
• • Used contraceptives, metformin, GLP-1RA, pioglitazone and contraceptives in the last 3 month.

Trial Officials